Modulation of TGF-beta signaling during progression of chronic liver diseases.
about
Hepatitis C virus and hepatocarcinogenesisAnchoring hepatic gene expression with development of fibrosis and neoplasia in a toxicant-induced fish model of liver injuryMolecular mechanisms of liver fibrosis in HIV/HCV coinfectionEffect of RhoA on transforming growth factor β1-induced rat hepatic stellate cell migration.Constructing the HBV-human protein interaction network to understand the relationship between HBV and hepatocellular carcinoma.NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.Viral hepatocarcinogenesis.Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder.Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells.Axl activates autocrine transforming growth factor-β signaling in hepatocellular carcinomaInherited liver shunts in dogs elucidate pathways regulating embryonic development and clinical disorders of the portal veinPhospho-specific Smad3 signaling: impact on breast oncogenesis.TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma.Coexpression of Smad7 and UPA attenuates carbon tetrachloride-induced rat liver fibrosisRole of the Transforming-Growth-Factor-β1 Gene in Late-Onset Alzheimer's Disease: Implications for the TreatmentAlcohol induced hepatic degeneration in a hepatitis C virus core protein transgenic mouse model.The crosstalk of RAS with the TGF-β family during carcinoma progression and its implications for targeted cancer therapy.Potential applications for cell regulatory factors in liver progenitor cell therapy.TGF-β in progression of liver diseaseDifferential Regulation of TGF-β/Smad Signaling in Hepatic Stellate Cells between Acute and Chronic Liver Injuries.Enhanced anti-fibrogenic effects of novel oridonin derivative CYD0692 in hepatic stellate cells.HAb18G/CD147 is involved in TGF-β-induced epithelial-mesenchymal transition and hepatocellular carcinoma invasion.HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug.Immunohistochemical study of hepatic fibropoiesis associated with canine visceral leishmaniasis.Growth factor- and cytokine-driven pathways governing liver stemness and differentiation.Master regulators in primary skin fibroblast fate reprogramming in a human ex vivo model of chronic wounds.The effect of down-regulation of Smad3 by RNAi on hepatic stellate cells and a carbon tetrachloride-induced rat model of hepatic fibrosis.Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
P2860
Q28283484-028491F7-4263-4D8F-906E-F46EF258DE37Q33894802-D17211A6-DC3D-46CA-A6F6-4CB52DEAA74FQ33907429-D56D9310-346A-471B-BDA0-21D12B534875Q34231374-53E82097-E160-4742-B75F-2A625AE18496Q34393261-9F2B2732-A8DB-45A5-B13D-F4806D530AAEQ34438060-47CDBAF2-4672-4340-990D-E7484EFF7A6FQ34617749-4D166C7E-74BA-4F85-95AB-25A008F62372Q34674982-55D81932-E2A4-48D5-B0D7-7ECEF800B3CDQ35649316-686481B3-269D-4136-A9A5-231CCA320432Q35669111-E40E7AAB-367B-45B2-B168-8F9FAA37E808Q35745584-D36BCBAE-1555-42B1-9AA6-9C764898F25EQ36116217-13F29488-D687-4476-BCB2-AA1F4913F8FCQ36237549-DD5BA24E-B6BB-44A6-9CAA-877E9C6D43CFQ36576803-A3603D4D-803E-44E3-9F97-764D9DF8568BQ36798886-573C6C42-A8EA-428C-AEDC-030D3345ECEFQ37684034-679E64A9-6D01-4D3F-8DBA-CA63083FFED2Q37780777-43B42015-ADE1-47D9-A1D4-5D1B9BFA812EQ37790160-EA649C3F-DBC4-4541-B4F4-FA346F754561Q37946756-7E41CB35-C3D2-45B9-A833-3F3D71FABCA6Q37998023-57E56C95-17DD-435A-99C9-2ACE10ECF50AQ38837216-F1989BCE-3064-4D64-A3FD-15FDB50D998EQ38973523-9284D803-0385-4CBF-A9BD-2B6C7A25862FQ39550377-22F63B65-1C5B-4E05-AD83-6916E09644D9Q40652746-7CBB0827-2462-411E-B9A2-F5D7B1DE2CCFQ42379051-07F9195A-79C2-49D8-B630-BF98B8537F9DQ46028248-BF555A1A-0456-4140-BA33-5A7A4E013E7EQ48309983-8A1618A2-1799-41A0-9995-A7FE9AC69DA6Q54345480-2E103C64-F465-4ADF-BFE7-B17E1A76EB5D
P2860
Modulation of TGF-beta signaling during progression of chronic liver diseases.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Modulation of TGF-beta signaling during progression of chronic liver diseases.
@ast
Modulation of TGF-beta signaling during progression of chronic liver diseases.
@en
Modulation of TGF-beta signaling during progression of chronic liver diseases.
@nl
type
label
Modulation of TGF-beta signaling during progression of chronic liver diseases.
@ast
Modulation of TGF-beta signaling during progression of chronic liver diseases.
@en
Modulation of TGF-beta signaling during progression of chronic liver diseases.
@nl
prefLabel
Modulation of TGF-beta signaling during progression of chronic liver diseases.
@ast
Modulation of TGF-beta signaling during progression of chronic liver diseases.
@en
Modulation of TGF-beta signaling during progression of chronic liver diseases.
@nl
P356
P1476
Modulation of TGF-beta signaling during progression of chronic liver diseases.
@en
P2093
Koichi Matsuzaki
P304
P356
10.2741/3423
P577
2009-01-01T00:00:00Z